Before most of America pours its first cup of coffee, millions of workers are already hours into their shifts, and they’re tired. Overnight warehouse workers are packing orders. Early-morning bus drivers are taking kids to school. ER nurses are handing off to the day team at 7 a.m. These workers aren’t just fatigued from long hours. Many are living with a real, diagnosable medical condition that goes unrecognized and untreated, sometimes for years. And the cost of that gap doesn’t stay invisible forever.
Shift Work Sleep Disorder (SWSD) affects up to 40% of U.S. shift workers. It can cause persistent insomnia, chronic fatigue, and impaired concentration. If left untreated, the effects compound, including increased risk of depression, Type 2 diabetes, and cardiovascular disease. Workplace consequences track a similar arc. Fatigued workers have higher rates of absenteeism, more on-the-job errors, and greater injury risk. For industries like logistics, healthcare, and transportation where precision and reliability are non-negotiable, this is a meaningful operational problem with a real dollar figure attached.
Luckily SWSD, along with other sleep disorders, is treatable. The access gap is the problem.
Why It Goes Undiagnosed
Getting diagnosed with a sleep disorder requires navigating a system that was never built for hourly workers. The standard diagnostic pathway is an overnight polysomnography (PSG) study at a sleep clinic. These studies require a patient to arrive at a facility during hours that are fundamentally incompatible with a night shift schedule. With one trained sleep specialist for every 43,000 Americans, the wait time for a referral and initial appointment can take months. At every step, the employee without scheduling flexibility faces an accessibility issue that salaried counterparts do not.
This isn’t just a healthcare access problem. It’s a structural mismatch between industries with a heavy concentration of sleep disorders and limitations within our care system.
The result is a large, diagnosable, treatable population cycling through impaired work performance, fatigue, and eventually preventable chronic illness — without ever receiving the intervention that could break the cycle.
The Business Case Is Straightforward
Employers in logistics, healthcare, transportation, and retail are sitting on an underrecognized liability. Workers living with untreated SWSD aren’t an abstraction, they’re the overnight warehouse team processing next-day orders, the nurses working back-to-back 12-hour nights, the long-haul drivers whose alertness is a matter of public safety.
